Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-156178

Chief Operating Officer gave up 494 shares (to pay taxes)

  • Chief Operating Officer acquired 1,625 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Powala Christopher Chief Operating Officer 2016-12-18 Option exercise +1,625 132,059 D
Powala Christopher Chief Operating Officer 2016-12-18 Shares withheld for taxes −494 $31.25 $15,438 131,565 D
Derivatives
Powala Christopher Chief Operating Officer 2016-12-18 Option exercise · Restricted Stock Units −1,625 4,875 D
Loading xslF345X03/doc4.xml…